(DAWN)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

DAWN Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-03-10 Blackman Samuel C. officer: Chief Medical Officer 1,233,660 S-Sale D 10,000 18.05 180,484.00
2023-03-07 Bender Jeremy director, officer: Chief Executive Officer 1,174,276 S-Sale D 12,500 20.01 250,113.75
2023-03-01 Grant Julie Papanek director 330,000 S-Sale D 25,000 18.61 465,302.50
2023-02-17 York Charles N II officer: COO, CFO and Secretary 262,128 S-Sale D 9,377 20.03 187,790.37
2023-02-16 York Charles N II officer: COO, CFO and Secretary 271,505 S-Sale D 930 19.57 18,202.89
2023-02-16 Bender Jeremy director, officer: Chief Executive Officer 1,186,776 S-Sale D 3,022 19.57 59,149.61
2023-02-16 Blackman Samuel C. officer: Chief Medical Officer 1,243,660 S-Sale D 674 19.57 13,192.20
2023-02-15 York Charles N II officer: COO, CFO and Secretary 33,750 M-Exempt D 2,250 0.00 0.00
2023-02-15 York Charles N II officer: COO, CFO and Secretary 15,125 M-Exempt D 1,375 0.00 0.00
2023-02-15 York Charles N II officer: COO, CFO and Secretary 272,435 M-Exempt A 2,250 0.00 0.00
2023-02-15 York Charles N II officer: COO, CFO and Secretary 270,185 M-Exempt A 1,375 0.00 0.00
2023-02-15 Bender Jeremy director, officer: Chief Executive Officer 71,250 M-Exempt D 4,750 0.00 0.00
2023-02-15 Bender Jeremy director, officer: Chief Executive Officer 39,190 M-Exempt D 3,562 0.00 0.00
2023-02-15 Bender Jeremy director, officer: Chief Executive Officer 1,189,798 M-Exempt A 4,750 0.00 0.00
2023-02-15 Bender Jeremy director, officer: Chief Executive Officer 1,185,048 M-Exempt A 3,562 0.00 0.00
2023-02-15 Blackman Samuel C. officer: Chief Medical Officer 21,563 M-Exempt D 1,437 0.00 0.00
2023-02-15 Blackman Samuel C. officer: Chief Medical Officer 13,065 M-Exempt D 1,187 0.00 0.00
2023-02-15 Blackman Samuel C. officer: Chief Medical Officer 1,244,334 M-Exempt A 1,437 0.00 0.00
2023-02-15 Blackman Samuel C. officer: Chief Medical Officer 1,242,897 M-Exempt A 1,187 0.00 0.00
2023-02-10 Blackman Samuel C. officer: Chief Medical Officer 1,241,710 S-Sale D 10,000 20.07 200,659.00
2023-02-01 Grant Julie Papanek director 355,000 S-Sale D 1,106 21.69 23,988.26
2023-02-01 Grant Julie Papanek director 356,106 S-Sale D 23,894 21.21 506,806.08
2023-01-23 Bender Jeremy director, officer: Chief Executive Officer 1,181,486 S-Sale D 12,500 22.00 274,987.50
2023-01-20 York Charles N II officer: COO, CFO and Secretary 268,810 S-Sale D 10,000 22.75 227,523.00
2023-01-17 York Charles N II officer: COO, CFO and Secretary 36,000 A-Award A 36,000 0.00 0.00
2023-01-17 York Charles N II officer: COO, CFO and Secretary 116,000 A-Award A 116,000 20.87 2,420,920.00
2023-01-17 Blackman Samuel C. officer: Chief Medical Officer 23,000 A-Award A 23,000 0.00 0.00
2023-01-17 Blackman Samuel C. officer: Chief Medical Officer 72,000 A-Award A 72,000 20.87 1,502,640.00
2023-01-17 Bender Jeremy director, officer: Chief Executive Officer 76,000 A-Award A 76,000 0.00 0.00
2023-01-17 Bender Jeremy director, officer: Chief Executive Officer 244,000 A-Award A 244,000 20.87 5,092,280.00
2023-01-10 Blackman Samuel C. officer: Chief Medical Officer 1,250,148 S-Sale D 2,500 23.20 58,011.25
2023-01-10 Blackman Samuel C. officer: Chief Medical Officer 1,252,648 S-Sale D 7,500 22.75 170,632.50
2023-01-03 Grant Julie Papanek director 380,000 S-Sale D 7,610 21.31 162,173.67
2023-01-03 Grant Julie Papanek director 387,610 S-Sale D 17,390 20.36 353,973.45
2022-12-21 Bender Jeremy director, officer: Chief Executive Officer 1,192,424 S-Sale D 12,500 20.32 253,968.75
2022-12-20 York Charles N II officer: COO, CFO and Secretary 276,497 S-Sale D 10,000 20.07 200,650.00
2022-12-12 Atlas Venture Fund XI, L.P. 10 percent owner 6,008,534 J-Other D 600,854 0.00 0.00
2022-12-08 Grant Julie Papanek director 405,000 S-Sale D 4,358 22.08 96,210.26
2022-12-02 Grant Julie Papanek director 409,358 S-Sale D 5,000 21.55 107,726.00
2022-12-01 Grant Julie Papanek director 414,358 S-Sale D 240 22.34 5,361.00
2022-12-01 Grant Julie Papanek director 414,598 S-Sale D 4,760 21.72 103,393.39
2022-12-01 Blackman Samuel C. officer: Chief Medical Officer 1,260,148 S-Sale D 900 22.16 19,940.04
2022-12-01 Blackman Samuel C. officer: Chief Medical Officer 1,261,048 S-Sale D 9,100 21.38 194,589.85
2022-11-21 Bender Jeremy director, officer: Chief Executive Officer 1,204,924 S-Sale D 400 21.38 8,552.00
2022-11-21 Bender Jeremy director, officer: Chief Executive Officer 1,205,324 S-Sale D 12,100 20.74 250,927.38
2022-11-21 York Charles N II officer: COO, CFO and Secretary 286,497 S-Sale D 300 21.39 6,417.00
2022-11-21 York Charles N II officer: COO, CFO and Secretary 286,797 S-Sale D 9,700 20.74 201,152.78
2022-11-16 York Charles N II officer: COO, CFO and Secretary 296,497 S-Sale D 430 21.46 9,227.71
2022-11-16 Blackman Samuel C. officer: Chief Medical Officer 1,270,148 S-Sale D 377 21.46 8,090.34
2022-11-16 Bender Jeremy director, officer: Chief Executive Officer 1,217,424 S-Sale D 1,513 21.46 32,468.68
2022-11-15 York Charles N II officer: COO, CFO and Secretary 16,500 M-Exempt D 1,375 0.00 0.00
2022-11-15 York Charles N II officer: COO, CFO and Secretary 295,776 M-Exempt A 1,375 0.00 0.00
2022-11-15 Blackman Samuel C. officer: Chief Medical Officer 14,252 M-Exempt D 1,187 0.00 0.00
2022-11-15 Blackman Samuel C. officer: Chief Medical Officer 1,270,525 M-Exempt A 1,187 0.00 0.00
2022-11-15 Bender Jeremy director, officer: Chief Executive Officer 42,752 M-Exempt D 3,562 0.00 0.00
2022-11-15 Bender Jeremy director, officer: Chief Executive Officer 1,218,937 M-Exempt A 3,562 0.00 0.00
2022-11-02 Grant Julie Papanek director 419,358 S-Sale D 5,000 20.01 100,069.00
2022-11-01 York Charles N II officer: COO, CFO and Secretary 294,401 S-Sale D 10,000 20.03 200,313.00
2022-11-01 Grant Julie Papanek director 424,358 S-Sale D 5,000 20.04 100,208.50
2022-11-01 Blackman Samuel C. officer: Chief Medical Officer 1,269,338 S-Sale D 10,000 20.01 200,050.00
2022-11-01 Bender Jeremy director, officer: Chief Executive Officer 1,215,375 S-Sale D 12,500 20.03 250,355.00
2022-10-04 Grant Julie Papanek director 429,358 S-Sale D 5,000 20.00 100,000.00
2022-10-03 York Charles N II officer: COO, CFO and Secretary 304,401 S-Sale D 10,000 20.05 200,473.00
2022-10-03 Grant Julie Papanek director 434,358 S-Sale D 5,000 20.06 100,315.00
2022-10-03 Bender Jeremy director, officer: Chief Executive Officer 1,227,875 S-Sale D 12,500 20.05 250,646.25
2022-10-03 Blackman Samuel C. officer: Chief Medical Officer 1,279,338 S-Sale D 10,000 19.99 199,852.00
2022-09-21 Grant Julie Papanek director 6,964,301 J-Other D 1,500,000 0.00 0.00
2022-09-21 Grant Julie Papanek director 8,464,301 S-Sale D 6,106 19.29 117,784.74
2022-09-21 Grant Julie Papanek director 8,470,407 S-Sale D 607,497 18.54 11,262,994.38
2022-09-21 Canaan XI L.P. 10 percent owner 6,964,301 J-Other D 1,500,000 0.00 0.00
2022-09-21 Canaan XI L.P. 10 percent owner 8,464,301 S-Sale D 6,106 19.29 117,784.74
2022-09-21 Canaan XI L.P. 10 percent owner 8,470,407 S-Sale D 607,497 18.54 11,262,994.38
2022-09-20 Grant Julie Papanek director 9,077,904 S-Sale D 2,266 20.10 45,546.60
2022-09-20 Grant Julie Papanek director 9,080,170 S-Sale D 146,404 19.50 2,854,878.00
2022-09-20 Canaan XI L.P. 10 percent owner 9,077,904 S-Sale D 2,266 20.10 45,546.60
2022-09-20 Canaan XI L.P. 10 percent owner 9,080,170 S-Sale D 146,404 19.50 2,854,878.00
2022-09-19 Atlas Venture Fund XI, L.P. 10 percent owner 6,609,388 J-Other D 600,854 0.00 0.00
2022-09-19 Grant Julie Papanek director 9,226,574 S-Sale D 76,725 20.57 1,578,233.25
2022-09-19 Canaan XI L.P. 10 percent owner 9,226,574 S-Sale D 76,725 20.57 1,578,233.25
2022-09-16 Grant Julie Papanek director 9,303,299 S-Sale D 3,722 22.04 82,032.88
2022-09-16 Grant Julie Papanek director 9,307,021 S-Sale D 111,585 21.53 2,402,425.05
2022-09-16 Canaan XI L.P. 10 percent owner 9,303,299 S-Sale D 3,722 22.04 82,032.88
2022-09-16 Canaan XI L.P. 10 percent owner 9,307,021 S-Sale D 111,585 21.53 2,402,425.05
2022-09-15 Grant Julie Papanek director 9,418,606 S-Sale D 3,314 23.73 78,641.22
2022-09-15 Grant Julie Papanek director 9,421,920 S-Sale D 47,967 22.79 1,093,167.93
2022-09-15 Canaan XI L.P. 10 percent owner 9,418,606 S-Sale D 3,314 23.73 78,641.22
2022-09-15 Canaan XI L.P. 10 percent owner 9,421,920 S-Sale D 47,967 22.79 1,093,167.93
2022-09-14 Grant Julie Papanek director 9,469,887 S-Sale D 384 24.29 9,327.36
2022-09-14 Grant Julie Papanek director 9,470,271 S-Sale D 105,727 23.68 2,503,615.36
2022-09-14 Canaan XI L.P. 10 percent owner 9,469,887 S-Sale D 384 24.29 9,327.36
2022-09-14 Canaan XI L.P. 10 percent owner 9,470,271 S-Sale D 105,727 23.68 2,503,615.36
2022-09-13 Grant Julie Papanek director 9,575,998 S-Sale D 1,003 25.01 25,085.03
2022-09-13 Grant Julie Papanek director 9,577,001 S-Sale D 86,644 24.39 2,113,247.16
2022-09-13 Canaan XI L.P. 10 percent owner 9,575,998 S-Sale D 1,003 25.01 25,085.03
2022-09-13 Canaan XI L.P. 10 percent owner 9,577,001 S-Sale D 86,644 24.39 2,113,247.16
2022-09-12 Nicholson Garry A director 33,900 A-Award A 33,900 25.84 875,976.00
2022-09-02 Grant Papanek Julie director 439,358 S-Sale D 5,000 23.82 119,107.50
2022-09-01 Bender Jeremy director, officer: Chief Executive Officer 1,240,375 S-Sale D 1,859 23.79 44,226.54
2022-09-01 Bender Jeremy director, officer: Chief Executive Officer 1,242,234 S-Sale D 10,641 23.15 246,354.05
2022-09-01 York Charles N II officer: COO, CFO and Secretary 314,401 S-Sale D 1,394 23.80 33,175.39

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.